Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1990-05-17
1992-02-25
Griffin, Ronald W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
536114, 536123, 435101, 435104, A61K 31715, C07B 3700
Patent
active
050913760
ABSTRACT:
Two new bacterial strains designated Zoogloea ramigera 115SL and Zoogloea ramigera 115SLR, a rifampicin resistant derivative of 115SL, have been developed. These strains are derived from the wild type Zoogloea ramigera 115, ATCC 25935. The two new strains produce a novel exopolysaccharide (EPS) and have several desirable characteristics that are absent from the parent strain, including improved culture properties, since they do not produce an EPS capsule layer like that of the parent 115 strain. The 115SL EPS is instead excreted as a slime layer which is not confined to the immediate area surrounding the cells. Since cells are not trapped within a floc where they grow at a reduced rate or die because of nutrient starvation, the new strains have more consistent and reproducible growth cycles and increased growth rates. As a consequence, exopolysaccharide production is more consistent and titers are higher. The separation of the EPS from the cells is also much easier and more economical. The other very important characteristic of strains 115SL and 115SLR is that they are able to receive foreight DNA using conventional techniques due to the absence of the capsule layer. This facilitates the application of recombinant DNA technology to control and produce novel exopolysaccharides.
REFERENCES:
patent: 3314801 (1967-04-01), Cadmus et al.
patent: 3406114 (1968-10-01), Goren et al.
patent: 3632570 (1972-01-01), Gill
patent: 3923782 (1975-12-01), Finn et al.
patent: 4329448 (1982-05-01), Cox et al.
patent: 4394447 (1983-07-01), Cadmus et al.
patent: 4508823 (1985-04-01), Olsen
patent: 4529797 (1985-07-01), Peik et al.
patent: 4567140 (1986-01-01), Voelskow et al.
patent: 4575551 (1986-03-01), Fujiyama et al.
patent: 4626504 (1986-12-01), Puhler et al.
patent: 4638059 (1987-01-01), Sutherland
patent: 4647657 (1987-03-01), Wan
patent: 4713449 (1987-12-01), Vanderslice et al.
patent: 4752580 (1988-06-01), Downs
patent: 4758356 (1988-07-01), Downs
patent: 4851393 (1989-07-01), Rha et al.
patent: 4948733 (1990-08-01), Easson, Jr. et al.
Norberg et al. (1982), Applied and Environmental Microbiology, vol. 44, No. 5, pp. 1231-1237.
Ditta et al., Proc. Natl. Acad. Sci., 77(12), 7347-7351 (Dec. 1980).
Farrah et al., Applied and Environ. Microbiol., 32(1), 33-37 (Jul. 1976).
Ish-Horowicz, Nucleic Acids Research, 9(13), 299-2998 (Jul. 10, 1981).
Okita et al., Structural Genes of Bacterial Glycogen Biosynthesis, 256, 6944-6952 (1981).
Parsons et al., Applied Microbiology, 21(4), 657-661 (Apr. 1971).
Sinskey et al., Biotechnology in Food Processing (1986).
Stauffer et al., J. Food Sci., 45, 946-952 (1980).
Norberg et al., Applied and Envir. Microbiol., vol. 44, pp. 1231-1237 (1982).
Harding et al., Abstracts, ASM 1986, 0-64.
Darzins et al., J. of Bacteriol., vol. 159, pp. 9-18 (1984).
Easson Jr. Donald D.
Peoples Oliver P.
Sinskey Anthony J.
Griffin Ronald W.
Kunz Gary L.
Massachusetts Institute of Technology
LandOfFree
Non-capsule exopolysaccharide from Zoogloea ramigera does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Non-capsule exopolysaccharide from Zoogloea ramigera, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Non-capsule exopolysaccharide from Zoogloea ramigera will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1893036